Release Date: 21/10/13 09:21 Summary: Raising up to $US17.5m to fast track Snake River Development Price Sensitive: Yes Download Document 531.18KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%